News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

A woman with longish blonde hair wearing a blazer, white shirt and light pants, crosses her arms while smiling under a flourescent sign which spells INFORMS with a fake hedge backdrop.
Media Coverage

The INFORMS Analytics+ Conference showcased how companies are turning advanced analytics and AI into measurable operational results

Read More
An illustration of people in an art gallery. Cartoon characters visit contemporary paintings and sculptures.
Media Coverage

Museums take this educational role seriously, and many institutions understand the need to sustain and broaden their appeal. “They used to be these big ivory towers of knowledge and history and thought and art,” said Hilary Knight, director of Change& in London and former director of digital at Tate. “Museums themselves are changing their role to be centers for discussion and encounter and to be much more participatory.”

Read More
A woman in a white lab coat looks to the left. Behind her are shelves and shelves of bottles and small boxes -- pharmaceuticals
Media Coverage

President Donald Trump is back at it with his tariff threats for pharma, promising massive levies on generic drug imports starting in 2028.

The president’s proposal — which was announced on Truth Social and has yet to be solidified via an official proclamation or notice — is framed as a push to encourage domestic drug manufacturing.

Trump outlined a 100% tariff on generic drugs originating from outside the U.S. starting on Aug. 1, 2028, which would be increased to 200% the following year. 

But the conditions that have long kept generic drug manufacturing out of the U.S. largely haven’t changed and Trump’s most recent plan might only succeed in making drugs more expensive while failing to bring factories stateside, according to Tinglong Dai, the Bernard T. Ferrari professor of business at Johns Hopkins Carey Business School.

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
'We Blew It': U.S. Reaches 'Explosive' COVID-19 Spread as Virus is Nearly Impossible to Control, Experts Say

'We Blew It': U.S. Reaches 'Explosive' COVID-19 Spread as Virus is Nearly Impossible to Control, Experts Say

Yahoo! Entertainment, November 13, 2020

With COVID-19 cases increasing in 46 states, 10 of which broke single-day records for new cases on Thursday, America has officially entered what experts refer to as the “exponential” phase of spread — a rapid multiplying of cases that can’t be contained through traditional measures. On Thursday alone, the U.S. saw 160,000 new cases of the virus, more than any day since the pandemic began.

COVID-19 Vaccines Are Here; Are Airlines Ready To Transport Them?

COVID-19 Vaccines Are Here; Are Airlines Ready To Transport Them?

Forbes, November 17, 2020

The airline industry has been a major beneficiary of the vaccine euphoria. First Pfizer, then Moderna announced vaccine candidates with a promised effectiveness of 90% or more. This excited investors and airline executives alike, with visions of pent-up demand creating packed planes with filled middle seats.

Panic Buying, Stockpiling Returns as COVID Cases Surge

Panic Buying, Stockpiling Returns as COVID Cases Surge

Fox 45 News, November 17, 2020

Another wave of COVID-19 cases is now triggering another wave of panic buying across the country. But the Maryland Department of Commerce says it has no regulatory oversight on grocers in the state. At this point, it's up to each individual company to set purchasing limits on high-demand items. In some instances, stores are starting to see empty shelves again.

From Testing to Distribution: The Logistics Behind COVID-19 Vaccines

From Testing to Distribution: The Logistics Behind COVID-19 Vaccines

wbur, November 18, 2020

Scientists work at the mAbxience biosimilar monoclonal antibody laboratory plant in Garin, Buenos Aires province, on August 14, 2020, where an experimental coronavirus vaccine will be produced for Latin America. - Argentina will manufacture while Mexico will pack and distribute in Latin America, except of Brazil, the vaccine against COVID-19 developed by the University of Oxford and the AstraZeneca laboratory.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine